JPY 1601.0
(0.25%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.85 Billion JPY | 9.59% |
2022 | 3.51 Billion JPY | -0.83% |
2021 | 3.54 Billion JPY | 18.0% |
2020 | 3 Billion JPY | 15.02% |
2019 | 2.61 Billion JPY | 9.15% |
2018 | 2.39 Billion JPY | 7.8% |
2017 | 2.21 Billion JPY | 7.74% |
2016 | 2.06 Billion JPY | 7.51% |
2015 | 1.91 Billion JPY | 12.8% |
2014 | 1.69 Billion JPY | 6.69% |
2013 | 1.59 Billion JPY | 9.62% |
2012 | 1.45 Billion JPY | -26.75% |
2011 | 1.98 Billion JPY | 55.07% |
2010 | 1.27 Billion JPY | 1.21% |
2009 | 1.26 Billion JPY | 8.74% |
2008 | 1.16 Billion JPY | 8.9% |
2007 | 1.06 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 2.51 Billion JPY | -34.85% |
2023 Q3 | 3.37 Billion JPY | 32.76% |
2023 Q2 | 2.53 Billion JPY | -1.7% |
2023 Q4 | 3.85 Billion JPY | 14.26% |
2023 Q1 | 2.58 Billion JPY | -26.5% |
2023 FY | 3.85 Billion JPY | 9.59% |
2022 Q4 | 3.51 Billion JPY | 14.61% |
2022 Q1 | 2.44 Billion JPY | -30.96% |
2022 Q3 | 3.06 Billion JPY | 27.92% |
2022 FY | 3.51 Billion JPY | -0.83% |
2022 Q2 | 2.39 Billion JPY | -2.02% |
2021 FY | 3.54 Billion JPY | 18.0% |
2021 Q2 | 2.58 Billion JPY | 9.1% |
2021 Q4 | 3.54 Billion JPY | 18.32% |
2021 Q3 | 2.99 Billion JPY | 15.98% |
2021 Q1 | 2.36 Billion JPY | -21.18% |
2020 Q4 | 3 Billion JPY | 16.44% |
2020 Q3 | 2.58 Billion JPY | 32.71% |
2020 Q1 | 1.72 Billion JPY | -33.88% |
2020 FY | 3 Billion JPY | 15.02% |
2020 Q2 | 1.94 Billion JPY | 12.58% |
2019 Q3 | 2.4 Billion JPY | 23.35% |
2019 Q2 | 1.95 Billion JPY | 13.39% |
2019 FY | 2.61 Billion JPY | 9.15% |
2019 Q1 | 1.72 Billion JPY | -28.08% |
2019 Q4 | 2.61 Billion JPY | 8.51% |
2018 Q4 | 2.39 Billion JPY | 13.89% |
2018 Q1 | 1.54 Billion JPY | -30.45% |
2018 FY | 2.39 Billion JPY | 7.8% |
2018 Q3 | 2.1 Billion JPY | 32.29% |
2018 Q2 | 1.58 Billion JPY | 2.88% |
2017 FY | 2.21 Billion JPY | 7.74% |
2017 Q3 | 2.03 Billion JPY | 30.76% |
2017 Q2 | 1.55 Billion JPY | 9.13% |
2017 Q1 | 1.42 Billion JPY | -30.7% |
2017 Q4 | 2.21 Billion JPY | 8.94% |
2016 Q3 | 1.85 Billion JPY | 13.11% |
2016 FY | 2.06 Billion JPY | 7.51% |
2016 Q4 | 2.06 Billion JPY | 11.23% |
2016 Q2 | 1.63 Billion JPY | 25.29% |
2016 Q1 | 1.3 Billion JPY | -31.8% |
2015 Q2 | 1.35 Billion JPY | 13.83% |
2015 Q1 | 1.18 Billion JPY | -30.08% |
2015 Q4 | 1.91 Billion JPY | 10.63% |
2015 FY | 1.91 Billion JPY | 12.8% |
2015 Q3 | 1.73 Billion JPY | 28.1% |
2014 FY | 1.69 Billion JPY | 6.69% |
2014 Q4 | 1.69 Billion JPY | 11.14% |
2014 Q3 | 1.52 Billion JPY | 24.92% |
2014 Q2 | 1.22 Billion JPY | 8.52% |
2014 Q1 | 1.12 Billion JPY | -29.19% |
2013 Q4 | 1.59 Billion JPY | 11.73% |
2013 FY | 1.59 Billion JPY | 9.62% |
2013 Q1 | 968.52 Million JPY | -33.32% |
2013 Q2 | 1.1 Billion JPY | 14.17% |
2013 Q3 | 1.42 Billion JPY | 28.87% |
2012 Q2 | 1.24 Billion JPY | -18.69% |
2012 Q1 | 1.52 Billion JPY | -22.94% |
2012 Q4 | 1.45 Billion JPY | 5.0% |
2012 FY | 1.45 Billion JPY | -26.75% |
2012 Q3 | 1.38 Billion JPY | 11.33% |
2011 Q4 | 1.98 Billion JPY | 43.72% |
2011 Q3 | 1.37 Billion JPY | 34.64% |
2011 Q1 | 795.16 Million JPY | -37.82% |
2011 Q2 | 1.02 Billion JPY | 28.87% |
2011 FY | 1.98 Billion JPY | 55.07% |
2010 Q1 | 875.69 Million JPY | -30.69% |
2010 Q2 | 1.09 Billion JPY | 24.88% |
2010 Q4 | 1.27 Billion JPY | 12.14% |
2010 Q3 | 1.14 Billion JPY | 4.28% |
2010 FY | 1.27 Billion JPY | 1.21% |
2009 Q4 | 1.26 Billion JPY | 11.98% |
2009 Q3 | 1.12 Billion JPY | 30.41% |
2009 Q2 | 865.17 Million JPY | 0.0% |
2009 FY | 1.26 Billion JPY | 8.74% |
2008 Q4 | 1.16 Billion JPY | 0.0% |
2008 FY | 1.16 Billion JPY | 8.9% |
2007 FY | 1.06 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -133.11% |
Euglena Co., Ltd. | 37.92 Billion JPY | 89.841% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | 40.66% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 73.577% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 81.969% |
Kao Corporation | 757.7 Billion JPY | 99.492% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 58.824% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 96.114% |
Shiseido Company, Limited | 615.1 Billion JPY | 99.374% |
Lion Corporation | 188.22 Billion JPY | 97.953% |
Mandom Corporation | 20.05 Billion JPY | 80.791% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -190.371% |
Milbon Co., Ltd. | 7.45 Billion JPY | 48.353% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 71.589% |
Fancl Corporation | 30.56 Billion JPY | 87.397% |
KOSÉ Corporation | 88.61 Billion JPY | 95.653% |
HABA Laboratories,Inc. | 3.92 Billion JPY | 1.821% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -22.351% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 88.417% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 83.975% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -262.059% |
Almado, Inc. | 1.94 Billion JPY | -97.939% |
I-ne CO., LTD. | 8.57 Billion JPY | 55.087% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 21.053% |
Liberta Co.,Ltd. | 3.88 Billion JPY | 0.797% |
AXXZIA Inc. | 2 Billion JPY | -92.012% |
S.T. Corporation | 12.01 Billion JPY | 67.924% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 93.851% |
Earth Corporation | 60.4 Billion JPY | 93.622% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 50.596% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -138.842% |
Ya-Man Ltd. | 3.97 Billion JPY | 3.113% |
MTG Co., Ltd. | 11.73 Billion JPY | 67.181% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | 7.657% |
SHOBIDO Corporation | 8.89 Billion JPY | 56.699% |
Artnature Inc. | 23.42 Billion JPY | 83.555% |
Pigeon Corporation | 19.34 Billion JPY | 80.089% |
Unicharm Corporation | 345.37 Billion JPY | 98.885% |
Paltac Corporation | 222.34 Billion JPY | 98.267% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 86.489% |